Single-agent dabrafenib for BRAFV600E-mutated histiocytosis

被引：40

作者：

Bhatia, Ankush ^{[1
]}

Ulaner, Gary ^{[2
]}

Rampal, Raajit ^{[3
]}

Hyman, David M. ^{[3
]}

Abdel-Wahab, Omar ^{[3
]}

Durham, Benjamin H. ^{[3
]}

Dogan, Ahmet ^{[4
]}

Ozkaya, Neval ^{[4
]}

Lacouture, Mario E. ^{[3
]}

Hajdenberg, Julio ^{[5
]}

Ganzel, Chezi ^{[6
]}

Diamond, Eli L. ^{[1
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Neurol, 1275 York Ave, New York, NY 10021 USA

[2] Mem Sloan Kettering Canc Ctr, Dept Radiol, 1275 York Ave, New York, NY 10021 USA

[3] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA

[4] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA

[5] Univ Florida, Hlth Canc Ctr, Orlando Hlth, Gainesville, FL 32611 USA

[6] Shaare Zedek Med Ctr, Dept Hematol, Jerusalem, Israel

来源：

HAEMATOLOGICA | 2018年 / 103卷 / 04期

基金：

美国国家卫生研究院;

关键词：

ERDHEIM-CHESTER DISEASE; LANGERHANS CELL HISTIOCYTOSIS; METASTATIC MELANOMA; SOLID TUMORS; FREE DNA; MUTATION; BRAF; VEMURAFENIB; EFFICACY; TRIAL;

D O I：

10.3324/haematol.2017.185298

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：E177 / E180

页数：4

共 15 条

[1] Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT) A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology [J].

Cheng, Donavan T. ;

Mitchell, Talia N. ;

Zehir, Ahmet ;

Shah, Ronak H. ;

Benayed, Ryma ;

Syed, Aijazuddin ;

Chandramohan, Raghu ;

Liu, Zhen Yu ;

Won, Helen H. ;

Scott, Sasinya N. ;

Brannon, A. Rose ;

O'Reilly, Catherine ;

Sadowska, Justyna ;

Casanova, Jacklyn ;

Yannes, Angela ;

Hechtman, Jaclyn F. ;

Yao, Jinjuan ;

Song, Wei ;

Ross, Dara S. ;

Oultache, Alifya ;

Dogan, Snjezana ;

Borsu, Laetitia ;

Hameed, Meera ;

Nafa, Khedoudja ;

Arcila, Maria E. ;

Ladanyi, Marc ;

Berger, Michael F. .

JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (03) :251-264

[2]

Diamond E L., 2017, JAMA Oncol

[3] Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease [J].

Diamond, Eli L. ;

Dagna, Lorenzo ;

Hyman, David M. ;

Cavalli, Giulio ;

Janku, Filip ;

Estrada-Veras, Juvianee ;

Ferrarini, Marina ;

Abdel-Wahab, Omar ;

Heaney, Mark L. ;

Scheel, Paul J. ;

Feeley, Nancy K. ;

Ferrero, Elisabetta ;

McClain, Kenneth L. ;

Vaglio, Augusto ;

Colby, Thomas ;

Arnaud, Laurent ;

Haroche, Julien .

BLOOD, 2014, 124 (04) :483-492

[4] Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial [J].

Falchook, Gerald S. ;

Long, Georgina V. ;

Kurzrock, Razelle ;

Kim, Kevin B. ;

Arkenau, Tobias H. ;

Brown, Michael P. ;

Hamid, Omid ;

Infante, Jeffrey R. ;

Millward, Michael ;

Pavlick, Anna C. ;

O'Day, Steven J. ;

Blackman, Samuel C. ;

Curtis, C. Martin ;

Lebowitz, Peter ;

Ma, Bo ;

Ouellet, Daniele ;

Kefford, Richard F. .

LANCET, 2012, 379 (9829) :1893-1901

[5] Reproducible and Sustained Efficacy of Targeted Therapy With Vemurafenib in Patients With BRAFV600E-Mutated Erdheim-Chester Disease [J].

Haroche, Julien ;

Cohen-Aubart, Fleur ;

Emile, Jean-Francois ;

Maksud, Philippe ;

Drier, Aurelie ;

Toledano, Dan ;

Barete, Stephane ;

Charlotte, Frederic ;

Cluzel, Philippe ;

Donadieu, Jean ;

Benameur, Neila ;

Grenier, Philippe A. ;

Besnard, Sophie ;

Ory, Jean-Paul ;

Lifermann, Francois ;

Idbaih, Ahmed ;

Granel, Brigitte ;

Graffin, Bruno ;

Hervier, Baptiste ;

Arnaud, Laurent ;

Amoura, Zahir .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (05) :411-U52

[6] Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation [J].

Haroche, Julien ;

Cohen-Aubart, Fleur ;

Emile, Jean-Francois ;

Arnaud, Laurent ;

Maksud, Philippe ;

Charlotte, Frederic ;

Cluzel, Philippe ;

Drier, Aurelie ;

Hervier, Baptiste ;

Benameur, Neila ;

Besnard, Sophie ;

Donadieu, Jean ;

Amoura, Zahir .

BLOOD, 2013, 121 (09) :1495-1500

[7] High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses [J].

Haroche, Julien ;

Charlotte, Frederic ;

Arnaud, Laurent ;

von Deimling, Andreas ;

Helias-Rodzewicz, Zofia ;

Hervier, Baptiste ;

Cohen-Aubart, Fleur ;

Launay, David ;

Lesot, Annette ;

Mokhtari, Karima ;

Canioni, Danielle ;

Galmiche, Louise ;

Rose, Christian ;

Schmalzing, Marc ;

Croockewit, Sandra ;

Kambouchner, Marianne ;

Copin, Marie-Christine ;

Fraitag, Sylvie ;

Sahm, Felix ;

Brousse, Nicole ;

Amoura, Zahir ;

Donadieu, Jean ;

Emile, Jean-Francois .

BLOOD, 2012, 120 (13) :2700-2703

[8] Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial [J].

Hauschild, Axel ;

Grob, Jean-Jacques ;

Demidov, Lev V. ;

Jouary, Thomas ;

Gutzmer, Ralf ;

Millward, Michael ;

Rutkowski, Piotr ;

Blank, Christian U. ;

Miller, Wilson H., Jr. ;

Kaempgen, Eckhart ;

Martin-Algarra, Salvador ;

Karaszewska, Boguslawa ;

Mauch, Cornelia ;

Chiarion-Sileni, Vanna ;

Martin, Anne-Marie ;

Swann, Suzanne ;

Haney, Patricia ;

Mirakhur, Beloo ;

Guckert, Mary E. ;

Goodman, Vicki ;

Chapman, Paul B. .

LANCET, 2012, 380 (9839) :358-365

[9] Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation [J].

Hervier, Baptiste ;

Haroche, Julien ;

Arnaud, Laurent ;

Charlotte, Frederic ;

Donadieu, Jean ;

Neel, Antoine ;

Lifermann, Francois ;

Villabona, Carles ;

Graffin, Bruno ;

Hermine, Olivier ;

Rigolet, Aude ;

Roubille, Camille ;

Hachulla, Eric ;

Carmoi, Thierry ;

Bezier, Maud ;

Meignin, Veronique ;

Conrad, Marie ;

Marie, Laurence ;

Kostrzewa, Elise ;

Michot, Jean-Marie ;

Barete, Stephane ;

Taly, Valerie ;

Cury, Karine ;

Emile, Jean-Francois ;

Amoura, Zahir .

BLOOD, 2014, 124 (07) :1119-1126

[10] Targeted treatment of brainstem neurohistiocytosis guided by urinary cell-free DNA [J].

Hunt, David ;

Milne, Paul ;

Fernandes, Peter ;

Bigley, Venetia ;

Collin, Matthew .

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2017, 4 (01)

← 1 2 →